Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rochester Medical Corporation was a prominent developer and manufacturer of innovative medical devices focused on urological and continence care. The company specialized in the design of silicone-based catheters, including the Magic3 intermittent catheter and the Spirit male external catheter. Their products were engineered to improve patient comfort, reduce the risk of infection, and provide alternatives to traditional latex-based devices. Headquartered in Stewartville, Minnesota, the company maintained a significant global presence with a strong focus on the North American and European markets. In 2013, Rochester Medical was acquired by C. R. Bard for approximately $262 million to enhance Bard's urology product portfolio. Following the acquisition, its operations were integrated into Bard, which was later acquired by Becton Dickinson in 2017.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rochester Medical.